Impact Bio at a Glance:
A Look into Our Company & Future
What we’ll cover at the Event
Meet The Leadership
Learn about WHO
Impact Biomedical is and
the management team leading the company!
IPO Sparks Growth
Hear more about our recently completed IPO
and what that means for
our company!
What's Next?
Discover what is coming up next for Impact as they look to progress four different platform opportunities!
Meet the Speakers
Frank D. Heuszel
Frank D. Heuszel is the CEO of Impact Biomedical, leveraging deep experience in executive management, finance, and strategic development. Previously holding senior roles in commercial banking, he became CEO of parent company DSS, Inc. in 2019.
He holds a business administration degree from the University of Texas at Austin and a J.D. from South Texas College of Law. His combined financial and legal expertise supports Impact’s strategic growth and direction.
Extensive Executive Experience
Legal and Financial Background
Track Record in Organizational Leadership
Todd Macko
Todd Macko, CFO of Impact Biomedical, brings over 25 years of expertise in financial management. He joined DSS Inc., Impact’s parent company, in 2021 and became CFO in May 2023.
His background includes strengths in financial planning, business process reengineering, and mergers and acquisitions. Macko holds a Bachelor’s in Accounting from the Rochester Institute of Technology, underscoring his solid foundation in finance and accounting.
Extensive Financial Leadership
Process Engineering Expertise
M&A and Strategic Growth
Mark Suseck
Mark Suseck is the Chief Operating Officer at Impact BioMedical, having joined the company in August 2023. He previously served as COO of DSS BioHealth Holdings and CEO of Vivacitas Oncology, where he led strategic development and clinical operations.
Suseck brings expertise in market strategy and commercialization, helping to scale operations at Impact. He holds an economics degree from Rutgers University and has completed executive training at the University of Michigan’s Business School.
Leadership Experience in Healthcare
Strategic and Operational Acumen
Academic and Executive Training
ABOUT US
Evolving Medical Ideologies & Technologies to Create Sustainable Alternatives to Modern Medicine
Our biopharmaceutical technologies have potential to advance treatment in oncology, neurology, and immunology. Consumer efforts include naturally based sugar alternatives, fragrances and insect repellents, as well antibacterial, antiviral, and antimicrobial technologies. A true spirit and desire of continuous improvement in healthcare result in continuous
discovery of new technologies.
COPYRIGHTS 2024 | TERMS & CONDITIONS